Clinical trial
Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)
NCT00220259 · Royal Brompton & Harefield NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00220259 |
|---|---|
| Title | Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study) |
| Official title | Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study) |
| Lead sponsor | Royal Brompton & Harefield NHS Foundation Trust, Other |
| Collaborators | Cystic Fibrosis Trust GlaxoSmithKline Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Fluticasone or placebo |
| Enrollment | 240 |
| Start date | May 1, 2001 |
| Completion | Feb 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 8, 2005 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: